Company Filing History:
Years Active: 2024
Title: Dmitry Chouljenko: Innovator in Oncolytic Virus Research
Introduction
Dmitry Chouljenko is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of oncolytic virus therapies. His innovative work focuses on harnessing the power of viruses to stimulate the immune system against cancer.
Latest Patents
Dmitry holds a patent for an oncolytic herpes simplex virus vector that expresses immune system-stimulatory molecules. This patent, titled "Oncolytic herpes simplex virus vectors expressing immune system-stimulatory molecules," includes an HSV vector comprising an expression cassette for one or more of IL12, IL15, and hIL15Receptor alpha subunit. This groundbreaking invention has the potential to enhance cancer treatment by improving immune responses.
Career Highlights
Dmitry Chouljenko is currently associated with Virogin Biotech Canada Ltd., where he continues to advance his research in oncolytic virus therapies. His work at Virogin Biotech is pivotal in developing innovative solutions for cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations
Dmitry collaborates with esteemed colleagues, including William Jia and Guoyu Liu. These partnerships enhance the research and development efforts at Virogin Biotech, fostering a collaborative environment that drives innovation.
Conclusion
Dmitry Chouljenko's contributions to the field of biotechnology, particularly in oncolytic virus research, highlight his role as a leading inventor. His patent and ongoing work at Virogin Biotech Canada Ltd. demonstrate his dedication to advancing cancer therapies.